
|Articles|January 13, 2020
Ergomed Acquires Ashfield Pharmacovigilance Inc.
Advertisement
Ergomed plc has announced the acquisition of Ashfield Pharmacovigilance Inc. from UDG Healthcare US Holdings, Inc. Ergomed has acquired the entire issued share capital of Ashfield PV for a total cash consideration of $10 million.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Evinova, Bristol Myers Squibb Partner to Apply AI to Global Clinical Development
2
SCOPE Summit 2026: How Payment Practices and Operational Burden Are Changing Site Behavior
3
SCOPE Summit 2026: How Sponsors Are Prioritizing AI Adoption Across Clinical Trials
4
ACT Brief: Purpose Meets Operational Focus, Acceleration Shifts Upstream, and AI Delivers Near-Term Impact
5



